FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/062875 [Registered on: 19/02/2024] Trial Registered Prospectively
Last Modified On: 25/01/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of Fentanyl and Midazolam with Bupivacaine in controlling nausea and vomiting in patients undergoing below waist surgeries. 
Scientific Title of Study   A comparative study between intrathecally administered Fentanyl & Midazolam with Bupivacaine for prevention of nausea & vomiting undergoing infraumbilical surgeries. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Chetan Shukla  
Designation  Senior Professor  
Affiliation  Principal Investigator (PI) 
Address  Department of Anaesthesia,Government Medical College, Rangbari, Kota, Rajasthan

Kota
RAJASTHAN
324005
India 
Phone    
Fax    
Email  chetanshukla_pallav@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Chetan Shukla  
Designation  Senior Professor  
Affiliation  Principal Investigator (PI) ( 89499 21637) 
Address  Department of Anaesthesia, Government Medical College, Rangbari, Kota, Rajasthan

Kota
RAJASTHAN
324005
India 
Phone    
Fax    
Email  chetanshukla_pallav@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Nidhi Punia  
Designation  PG student  
Affiliation  Government Medical College, Kota 
Address  Department of Anesthesiology, Government Medical College, kota

Kota
RAJASTHAN
324001
India 
Phone  8107456268  
Fax    
Email  nidhipoonia123@gmail.com  
 
Source of Monetary or Material Support  
Government Medical College and Hospital, Rangbari, Kota 
 
Primary Sponsor  
Name  Government Medical College, Kota  
Address  Government Medical College, Rangbari, Kota Rajasthan  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Chetan Shukla   Government Medical College and Hospital Kota  Department of Anesthesiology,Government Medical College, Rangbari, Kota Rajasthan
Kota
RAJASTHAN 
8949921637

chetanshukla_pallav@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical committee, Government Medical College,Kota  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Inj. Fentanyl and Inj. Midazolam  0.25mL Fentanyl (12.5microgm) Intrathecally, once before surgery 0.25mL Midazolam (1.25mg) Intrathecally, once before surgery Patients will be observed for 48 hours post op. 
Comparator Agent  Inj. Fentanyl(12.5microgm) and Inj. Midazolam(1.25mg)  0.25mL Fentanyl (12.5microgm) Intrathecally, once before surgery 0.25mL Midazolam (1.25mg) Intrathecally, once before surgery Patients will be observed for 48 hours post op. 
 
Inclusion Criteria  
Age From  22.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  ASA physical status 1 and 2. Patients posted for infraumbilical surgeries. 
 
ExclusionCriteria 
Details  Patients with hypertension, CAD, rental and hepatic disease. Patients with skin disease at the site of injection. Contraindication to regional anaesthesia  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
To compare which amongst Fentanyl & Midazolam is better for prevention of nausea & vomiting undergoing infraumbilical surgeries.  48 hours post op 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the vital parameters between the two groups & to study any side effects or complications & treat them with utmost care

 
48 hours post op 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   21/02/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The most common and discomforting symptoms which follow
anaesthesia and surgery are emesis and pain. Sometimes nausea and vomiting may be so distressing especially after minor and ambulatory surgeries that it delays the hospital discharge.One of the key factors in this regard is visceral pain and pain resulting from traction of peritoneum. The present study is done to compare the effectiveness of adding fentanyl and midazolam with Bupivacaine in preventing the incidence of intra-operative and post-operative nausea and vomiting.
 
Close